Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
01 21STRIDES PHARMA INTL
02 2AZURITY
03 1METACEL PHARMS LLC
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2041-09-29
US Patent Number : 11850225
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3488
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-09-29
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2041-09-29
US Patent Number : 11850225
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3489
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-09-29
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2041-09-29
US Patent Number : 11850225
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3489
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-09-29
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2041-09-29
US Patent Number : 11850225
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3489
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-09-29
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2041-09-29
US Patent Number : 11850225
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3488
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-09-29
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2041-09-29
US Patent Number : 11850225
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3488
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-09-29
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2039-07-29
US Patent Number : 10792262
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3263
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2039-07-29
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2039-07-29
US Patent Number : 10792262
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3263
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2039-07-29
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2039-07-29
US Patent Number : 10792262
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3263
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2039-07-29
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2041-09-29
US Patent Number : 11491125
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3488
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-09-29
